Skip to main content

Table 6 Analysis of PLR, MLR and SII in general population

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Parameter ESCC patients Tumor-free people
PLR 174.72 117.01
MLR 0.21 0.30
SII 829.37 376.76